ProPhase Labs, Inc.
PRPH · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $6,770 | $44,384 | $122,647 | $79,042 |
| % Growth | -84.7% | -63.8% | 55.2% | – |
| Cost of Goods Sold | $6,920 | $28,145 | $51,993 | $46,228 |
| Gross Profit | -$150 | $16,239 | $70,654 | $32,814 |
| % Margin | -2.2% | 36.6% | 57.6% | 41.5% |
| R&D Expenses | $594 | $1,418 | $652 | $520 |
| G&A Expenses | $37,885 | $34,502 | $46,407 | $22,493 |
| SG&A Expenses | $37,885 | $34,502 | $46,407 | $22,493 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $1,932 | $0 | $0 |
| Operating Expenses | $38,479 | $37,852 | $47,059 | $23,013 |
| Operating Income | -$38,629 | -$21,613 | $23,595 | $9,801 |
| % Margin | -570.6% | -48.7% | 19.2% | 12.4% |
| Other Income/Exp. Net | -$3,701 | -$785 | -$687 | -$4,496 |
| Pre-Tax Income | -$42,330 | -$22,398 | $22,908 | $5,305 |
| Tax Expense | $7,195 | -$6,018 | $4,445 | -$968 |
| Net Income | -$53,364 | -$16,782 | $18,463 | $6,273 |
| % Margin | -788.2% | -37.8% | 15.1% | 7.9% |
| EPS | -2.61 | -0.98 | 1.17 | 0.41 |
| % Growth | -166.3% | -183.8% | 185.4% | – |
| EPS Diluted | -2.61 | -0.98 | 1.02 | 0.4 |
| Weighted Avg Shares Out | 19,079 | 17,207 | 15,845 | 15,172 |
| Weighted Avg Shares Out Dil | 19,079 | 17,207 | 18,651 | 18,393 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $78 | $153 | $642 |
| Interest Expense | $3,350 | $1,275 | $764 | $1,148 |
| Depreciation & Amortization | $6,644 | $6,698 | $5,061 | $4,935 |
| EBITDA | -$32,336 | -$14,827 | $28,733 | $11,388 |
| % Margin | -477.6% | -33.4% | 23.4% | 14.4% |